We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.06%
5 Year Est. Return
+670.57%
10 Year Est. Return
AUM
$2.97B
AUM Growth
-$668M
Cap. Flow
+$51.1M
Cap. Flow %
1.72%
Top 10 Hldgs %
63.58%
Holding
795
New
186
Increased
196
Reduced
157
Closed
179

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$120M
2
LLY icon
Eli Lilly
LLY
+$117M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$70.3M
4
AMZN icon
Amazon
AMZN
+$16.6M
5
PLTR icon
Palantir
PLTR
+$16.1M

Sector Composition

Rank Sector Weight
1 Technology 35.38%
2 Financials 18.17%
3 Healthcare 16.24%
4 Consumer Discretionary 10.31%
5 Communication Services 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNY
626
PUT
Bank of New York Mellon
BNY
$108B
-22,400
Closed -$10.1K
BYD icon
627
Boyd Gaming
BYD
$6.47B
-12,500
Closed -$689K
BYD icon
628
PUT
Boyd Gaming
BYD
$6.47B
-22,700
Closed -$25K
CCO icon
629
Clear Channel Outdoor Holdings
CCO
$1.23B
-85,000
Closed -$120K
CDROW icon
630
Codere Online Luxembourg Warrants
CDROW
$5.79M
-91,312
Closed -$94.1K
CGC
631
CALL
Canopy Growth
CGC
$375M
-27,700
Closed -$4.47K
CGC
632
Canopy Growth
CGC
$375M
-22,700
Closed -$146K
CGC
633
PUT
Canopy Growth
CGC
$375M
-50,400
Closed -$38.1K
CHWY icon
634
CALL
Chewy
CHWY
$8.54B
-10,000
Closed -$19K
CL icon
635
CALL
Colgate-Palmolive
CL
$72.6B
-42,300
Closed -$154K
CRGX
636
DELISTED
CARGO Therapeutics
CRGX
-554,305
Closed -$9.1M
CTSH icon
637
CALL
Cognizant
CTSH
$21.5B
-50,000
Closed -$10K
DD icon
638
CALL
DuPont de Nemours
DD
$18.6B
-39,833
Closed -$7.5K
DD icon
639
DuPont de Nemours
DD
$18.6B
-8,803
Closed -$889K
DD icon
640
PUT
DuPont de Nemours
DD
$18.6B
-2,788
Closed -$5.81K
DIST
641
DELISTED
Distoken Acquisition Corp
DIST
-40,000
Closed -$431K
ELAN icon
642
CALL
Elanco Animal Health
ELAN
$12.4B
-13,400
Closed -$335
ELAN icon
643
PUT
Elanco Animal Health
ELAN
$12.4B
-13,400
Closed -$4.02K
ELV icon
644
Elevance Health
ELV
$81.9B
-610
Closed -$331K
ELV icon
645
PUT
Elevance Health
ELV
$81.9B
-5,600
Closed -$41.4K
EQR icon
646
CALL
Equity Residential
EQR
$25.4B
-10,400
Closed -$4.42K
EVLV icon
647
CALL
Evolv Technologies
EVLV
$943M
-200,000
Closed -$5K
FOA icon
648
Finance of America Companies
FOA
$204M
-1,315
Closed -$6.48K
FULC icon
649
CALL
Fulcrum Therapeutics
FULC
$248M
-1,300
Closed -$650
FULC icon
650
Fulcrum Therapeutics
FULC
$248M
-2,964,127
Closed -$18.4M

Similar funds

Cowen and Company's Q3 2024 Portfolio in Review

As of Q3 2024, Cowen and Company held 795 positions worth $2.97B, down 18% from $3.64B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Cowen and Company's Q3 2024 filing shows 186 new, 196 increased, 157 reduced and 179 closed positions. Its largest new stake was Eli Lilly: 130,399 shares worth $116M. The largest sale was Meta Platforms (Facebook), an estimated $239M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.

  • Cowen and Company's largest Q3 2024 buy was Eli Lilly: 130,399 shares worth $116M.
  • Cowen and Company added most to Microsoft in Q3 2024, an estimated $120M increase.
  • Cowen and Company's biggest Q3 2024 reduction was Meta Platforms (Facebook), cutting an estimated $239M.
  • Cowen and Company fully exited Avidity Biosciences in Q3 2024, selling an estimated $210M.
  • Cowen and Company's ten largest holdings make up 64% of its $2.97B portfolio in Q3 2024.
  • Cowen and Company opened 186 new positions and closed 179 in Q3 2024.
  • Cowen and Company's portfolio value fell 18% quarter-over-quarter to $2.97B.

Based on Cowen and Company's 13F filing for Q3 2024, filed 12 Nov 2024.